Artal Group S.A.

Fundamental concentrated ★Highest signal consumer_discretionary specialist (76%) CIK 1053906
League rank
#21
in Fundamental concentrated · #24 overall
Long book
$1.01B
Q1 2026
Positions
2
Top-10 weight
100%
concentration
Last quarter
+7.9%
SPY +14.8%
Turnover
0%
of book per quarter

Strategy in plain words

auto-generated from filings

Artal Group S.A. is a concentrated fundamental stock-picker, specialised in consumer_discretionary (76% of the long book), running a $1.01B US long book across 2 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The book barely moves quarter to quarter — a patient, low-turnover holder. Current anchor positions: CAVA GROUP INC, LEXICON PHARMACEUTICALS INC.

Over the last 9 quarters its long book ran on average 2.3pp per quarter behind the S&P 500, beating the index in 3 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
+7.9%
Q2 2024
+22.9%
Q3 2024
-12.9%
Q4 2024
-24.6%
Q1 2025
+5.2%
Q2 2025
-18.5%
Q3 2025
-5.7%
Q4 2025
+37.4%
Q1 2026
+7.9%

Sector allocation

Consumer discretionary
76%
Healthcare
24%

Long book by quarter

$3.88B
Q1 2024
$3.89B
Q2 2024
$2.38B
Q3 2024
$1.17B
Q4 2024
$884.2M
Q1 2025
$930.2M
Q2 2025
$758.2M
Q3 2025
$714.6M
Q4 2025
$1.01B
Q1 2026

What does Artal Group own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
CAVA CAVA GROUP INCConsumer discretionary9.5M$769.2M76.1%Held
LXRX LEXICON PHARMACEUTICALS INCHealthcare154.7M$241.4M23.9%+13.6%

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 14, 20262$1.01B canonicalSEC ↗
Q4 202513F-HRFeb 12, 20262$714.6M canonicalSEC ↗
Q3 202513F-HRNov 12, 20252$758.2M canonicalSEC ↗
Q2 202513F-HRAug 13, 20252$930.2M canonicalSEC ↗
Q1 202513F-HRMay 14, 20252$884.2M canonicalSEC ↗
Q4 202413F-HRFeb 14, 20252$1.17B canonicalSEC ↗
Q3 202413F-HRNov 13, 20242$2.38B canonicalSEC ↗
Q2 202413F-HRAug 14, 2024114$3.92B canonicalSEC ↗
Q1 202413F-HR/ARESTATEMENTMay 17, 2024113$3.93B canonicalSEC ↗
Q1 202413F-HRMay 13, 2024112$3.92B SEC ↗